236 related articles for article (PubMed ID: 1487164)
41. [The clinical significance of anti-gliadin antibodies determination in blood of children with suspected celiac diseases].
van der Meer BW; Mearin ML; Peña AS; van Tol MJ; Lamers CB; Dooren LJ
Tijdschr Kindergeneeskd; 1993 Feb; 61(1):7-12. PubMed ID: 8493702
[TBL] [Abstract][Full Text] [Related]
42. Postpubertal gluten challenge in coeliac disease.
Mäki M; Lähdeaho ML; Hällström O; Viander M; Visakorpi JK
Arch Dis Child; 1989 Nov; 64(11):1604-7. PubMed ID: 2604420
[TBL] [Abstract][Full Text] [Related]
43. Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology.
Arranz E; Ferguson A
Gastroenterology; 1993 May; 104(5):1263-72. PubMed ID: 8482440
[TBL] [Abstract][Full Text] [Related]
44. Application of ELISA method to determine antigliadin antibodies in children with coeliac disease.
Kolek A; Fischerová E; Kos V; Gregar I
Acta Univ Palacki Olomuc Fac Med; 1989; 122():183-92. PubMed ID: 2530815
[TBL] [Abstract][Full Text] [Related]
45. Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy.
McMillan SA; Haughton DJ; Biggart JD; Edgar JD; Porter KG; McNeill TA
BMJ; 1991 Nov; 303(6811):1163-5. PubMed ID: 1747612
[TBL] [Abstract][Full Text] [Related]
46. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy.
Abrams JA; Diamond B; Rotterdam H; Green PH
Dig Dis Sci; 2004 Apr; 49(4):546-50. PubMed ID: 15185855
[TBL] [Abstract][Full Text] [Related]
47. Determining IgA and IgG antigliadin, IgA antitransglutaminase, and antiendomysial antibodies in monkey esophagus and in umbilical cord for diagnosis of celiac disease in developing countries.
Bahia M; Penna FJ; Sampaio IB; Silva GM; Andrade EM
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):551-8. PubMed ID: 18030232
[TBL] [Abstract][Full Text] [Related]
48. [Predictive value of serological tests in the diagnosis of celiac disease].
Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
[TBL] [Abstract][Full Text] [Related]
49. No harm from five year ingestion of oats in coeliac disease.
Janatuinen EK; Kemppainen TA; Julkunen RJ; Kosma VM; Mäki M; Heikkinen M; Uusitupa MI
Gut; 2002 Mar; 50(3):332-5. PubMed ID: 11839710
[TBL] [Abstract][Full Text] [Related]
50. Serological markers for coeliac disease: changes with time and relationship to enteropathy.
Johnston SD; Watson RG; McMillan SA; Evans AE; Love AH
Eur J Gastroenterol Hepatol; 1998 Mar; 10(3):259-64. PubMed ID: 9585032
[TBL] [Abstract][Full Text] [Related]
51. Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy?
Sategna-Guidetti C; Ferfoglia G; Bruno M; Pulitano R; Roccatello D; Amore A; Coppo R
Gut; 1992 Apr; 33(4):476-8. PubMed ID: 1582590
[TBL] [Abstract][Full Text] [Related]
52. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease.
Vetrano S; Zampaletta U; Anania MC; Di Tola M; Sabbatella L; Passarelli F; Maffia C; Sanjust MG; Lettieri F; De Pità O; Picarelli A
Dig Liver Dis; 2007 Oct; 39(10):911-6. PubMed ID: 17719860
[TBL] [Abstract][Full Text] [Related]
53. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study.
Catassi C; Rossini M; Rätsch IM; Bearzi I; Santinelli A; Castagnani R; Pisani E; Coppa GV; Giorgi PL
Gut; 1993 Nov; 34(11):1515-9. PubMed ID: 8244135
[TBL] [Abstract][Full Text] [Related]
54. [Antiendomysial antibodies: current role in the diagnosis of celiac disease compared to antigliadin antibodies].
Gemme G; Delogu A; Nobili F; Galeazzi G; Mariani P; Triglione P; Bonamico M
Pediatr Med Chir; 1993; 15(6):595-7. PubMed ID: 8197021
[TBL] [Abstract][Full Text] [Related]
55. IgA endomysium antibody: a valuable tool in the screening of coeliac disease but not its follow-up.
Valentini RA; Andreani ML; Corazza GR; Gasbarrini G
Ital J Gastroenterol; 1994; 26(6):279-82. PubMed ID: 7949263
[TBL] [Abstract][Full Text] [Related]
56. New immunofluorescent blood test for gluten sensitivity.
Unsworth DJ; Manuel PD; Walker-Smith JA; Campbell CA; Johnson GD; Holborow EJ
Arch Dis Child; 1981 Nov; 56(11):864-8. PubMed ID: 7030226
[TBL] [Abstract][Full Text] [Related]
57. IFL- and ELISA-antigliadin antibodies recognize different antigenic reactivities from those of R1-antireticulin and antiendomysial antibodies.
Volta U; Molinaro N; De Franceschi L; Fratangelo D; Bianchi FB
Ital J Gastroenterol; 1995 Mar; 27(2):64-8. PubMed ID: 7579593
[TBL] [Abstract][Full Text] [Related]
58. Human oesophagus: a convenient antigenic substrate for the determination of anti-endomysium antibodies in the serological diagnosis of coeliac disease.
Uibo O; Lambrechts A; Mascart-Lemone F
Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):37-40. PubMed ID: 7866808
[TBL] [Abstract][Full Text] [Related]
59. Differentiation of coeliac disease and other malabsorption diseases using specific serum antigliadin IgG subclass profiles and IgA1 levels.
Gonczi J; Skerritt JH; Mitchell JD
Int Arch Allergy Immunol; 1992; 98(4):377-85. PubMed ID: 1422265
[TBL] [Abstract][Full Text] [Related]
60. Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis.
Hällström O
Gut; 1989 Sep; 30(9):1225-32. PubMed ID: 2806989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
